Wednesday, June 3rd, 2015

Opening Remarks


Roundtable: Digital Health –
Scaling in NYC and Beyond

Topics Covered:

  • What are the pain points for payers? Providers?
  • How do competitive market dynamics shape priorities for payers and providers?
  • Who has the authority to purchase, and then drive adoption?
  • What are the keys to a successful customer relationship with payer/provider organizations that are frequently overlooked by entrepreneurs?
  • For an entrepreneur, how do you qualify a great potential customer/pilot partner?

  • Lee Wrubel, Partner, Flare Capital Partners (Moderator)
  • Sander Duncan, North Shore Ventures, North Shore-LIJ
  • Bob Sheehy, former CEO, United Healthcare
  • Mony Weschler, Chief Strategist, Montefiore Medical Center

Startup Company Presentations

Track 1:
Emergency MCG
Track 2:

Networking Break


Roundtable: Regulation A+

The Democratization of Capitalism


The JOBS Act makes it simpler for entrepreneurs to raise capital. A key portion of the JOBS Act is Regulation A+. Effective June 19th, A+ could have a dramatic impact on the number of small IPO’s in the United States and could impact the capital markets overall. It offers great allure for growth companies seeking capital.

This panel session will provide an overview of how REg. A+ works and what it means financing growth companies:

Topics Covered:

  • Investor Impact. From friends/family to institutions: the impact and benefits of Reg A+

  • Reg A vs. Reg D vs. Reg A+.  An overview of the primary SEC regulations

  • IPO’s in America.  Reg A impact on the future of IPO’s in the US

  • Market Structure. Flash Crash and High Frequency trading vs. long term investing


  • Brett Johnson, CEO, OneMedMarket (Moderator)
  • Sunny Barkats, JSBarkats PLC
  • Tyler Gellasch, Partner & General Counsel, WR Hambrecht + Co.

Startup Company Presentations

Track 1:
Ugo Health
Inbox Health
Track 2:
Genomic Expression
Meals to Heal
Motion Traxx

Roundtable: The Empowered Consumer – The Revolution Begins…


Now, more than ever, consumers are taking control of their own health status and care. The patient-to-consumer movement has begun and startups are spearheading the revolution.

This roundtable will explore the above hypothesis with three leading thinkers and companies that are leading the charge.


  • Artem Petakov, Co-founder, Noom
  • Esther Dyson, Founder, HICCup; Chairman, EDventure Holdings
  • Jeff Dachis, Founder & CEO, OneDrop
  • Calvin Hwang, Chief Experience Officer & Board Member, CityMD
  • Anthony Manson, Chief Organizer, Health 2.0 NYC (Moderator)

Closing Remarks

Cocktails, Hors d’Oeuvres & Networking – Sponsored by The Macallan Scotch

NOOM_DSC_5072 (1)

Saeju Jeong is the CEO and co-Founder on Noom, Inc., a mobile health company that harnesses the power of technology and the empathy of real human coaches to deliver successful behavior change programs that scale.

As the son of a physician who founded South Korea’s largest private hospital (Chonnam Hospital), where Saeju still sits as an active board member, Saeju had an intense desire to help people. In 2008, together with his close friend, ex-Googler and Princeton graduate Artem Petakov, Saeju founded Worksmart Labs, which is now known as Noom Inc.

Noom’s research-backed products help people with chronic conditions and diseases achieve real, positive outcomes.  Noom’s consumer app, Noom Coach, which helps users lose weight and live healthier has fully translated mobile applications in South Korea, Japan and Germany, where the company also has regional offices. Through Noom Coach’s success, the company has seen more than 32 million downloads worldwide.

Building on the company’s flagship Coach platform (which delivers an average weight loss of 10 lbs. and 65% retention of users over a four month period) the company recently launched, Noom Health, designed specifically for payers, providers and employers to use in the delivery of behavior change programs to prevent chronic diseases such as diabetes.

Noom was awarded a grant from the National Institutes of Health (NIH) and the City of Seoul’s Life Insurance Fund (LIF) to conduct studies on preventative health care.  The company was selected to participate in the 2014 New York Digital Health Accelerator (NYDHA) through which it has launched pilot programs with Aetna, New York Presbyterian and Greater Buffalo United Accountable Health Network.

Saeju sits on South Korea’s Ministry of Science & Technology’s steering committee and the board of Chonnam Hospital, South Korea’s largest private hospital.


Lee Wrubel brings more than two decades of venture capital experience to his role of General Partner at Flare Capital Partners (formerly Foundation Medical Partners) where he focuses on healthcare information and digital health technology companies.

Prior to Flare Capital Partners, Lee was a cofounder of Foundation Medical Partners, an early stage healthcare technology venture capital firm, whose investments include Rise Health (Best Doctors), CardioMEMS (St Jude Medical), and CardioNet. Prior to Foundation, Lee served as an investment professional with Highland Capital Partners and Canaan Partners where he worked closely with the management of a large number of private companies. Lee began his business career as a consultant at The Wilkerson Group, a healthcare-focused management consulting company.

Lee earned an A.B. from Lafayette College, an M.D. and Masters in Public Health from Tufts University, and an M.B.A. from Columbia University. Lee also completed a pediatric internship at Mount Sinai Medical Center in New York.

Lee is an Executive in Residence at Columbia University, and a member of the Advisory Board of the Eugene Lang Center for Entrepreneurship at Columbia Business School. Lee is also an advisor to General Assembly and a founder of the Coalition to Cure Calpain 3, a non-profit research organization founded to fund research into calpainopathy, a rare form of muscular dystrophy.


Dr. Peter Fleischut is Chief Innovation Officer for NewYork-Presbyterian Hospital (NYP). In addition, Dr. Fleischut serves as the Founding Director of the Center for Perioperative Outcomes (CPO) and is the Director of the Main Operating Rooms at NYP.

Dr. Fleischut has been instrumental in creating various technologies to improve efficiency, communications, and quality metrics through the use of perioperative mobile applications and integration of data from various electronic health records.

Dr. Fleischut is developing and studying interdisciplinary, innovative, new and emerging clinical decision support technologies, with a goal of improving the quality of care at NYP.  Dr. Fleischut is also interested in developing and utilizing preoperative, intraoperative, and postoperative data for outcomes data analyses to determine best practices in anesthesia administration.

Dr. Fleischut, a graduate of Jefferson Medical College and the Wharton Program for Working Professionals at the University of Pennsylvania, completed his residency training in Anesthesiology at NYP/WCMC. During his residency, he was awarded the Van Poznak Anesthesiology Research Scholarship and an educational grant from the Foundation for Anesthesiology Education and Research (FAER), serving as Resident Scholar.

Dr. Fleischut has received several awards, including the David A. Leach Award for Innovation in Quality from the Accreditation Council on Graduate Medical Education, the John M. Eisenberg Patient Safety and Quality Award from the National Quality Forum and The Joint Commission, and the Weill Cornell Medical College Healthcare Leadership Award.  In 2013, he was named one of twelve Up and Comers by Modern Healthcare, recognizing healthcare leaders under the age of 40, and was also named Physician-of-the-Year at NYP/Weill Cornell. In 2014, he was named one of the 25 healthcare leaders under 40 by Becker’s Hospital Review.


Jeffrey Dachis is the CEO and Founder of OneDrop, a simple, powerful and convenient mobile platform for managing diabetes, born from his own experience as a newly diagnosed Type 1 LADA (September 2013). His desire to bring the quantified self movement, internet of things, big data and mobile computing to people with diabetes in a simple, fully integrated solution led him to create the One Drop drop platform – which won “Best Design” at the LAUNCH 2015 Festival.

Jeff is a digital visionary and a serial entrepreneur. Considered one of the early pioneers in the development of the World Wide Web, Jeff was involved in the creation of the first banner ad, the creation of the first web animation, and has digital work exhibited as part of the San Francisco Museum of Modern Art’s permanent collection. As the Founder, CEO and Chairman of Dachis Group, he helped coin the term ‘Social Business’, set the vision and strategy for its Social Business consulting practice and the development of its big data social analytics platform, and drove the eventual strategic exit to Sprinklr, the leading social experience management platform. He is also the Co-Founder, former CEO and Chairman of Razorfish (acquired by Publicis), the world’s largest digital marketing solutions firm, where he bootstrapped the company and led it through its successful $55MM IPO.

Jeff is a Ernst and Young Entrepreneur of the Year winner (NYC 2001) and finalist (Austin 2012). He is an active mentor and investor with TechStars and Founder’s Institute, and serves or has served on advisory boards for companies including Sprinklr, Bazaarvoice, OfferPop, Ferris, and SocialWare. Jeff is a frequent guest lecturer at the University of Texas at Austin and New York University; he has a MA from NYU, and a double Liberal Arts degree from SUNY Purchase.


Bob Sheehy is the former CEO of United Healthcare, where he worked for more than 20 years. Bob led all of United’s acquisitions that were health plan focused during a period of tremendous corporate growth. Previously, he served as president and chief operating officer of UnitedHealthcare and senior vice president of UnitedHealth Group.


Brett Johnson is the Founder and CEO of OneMedMarket, a New York based research and media company whose mission is to identify and provide a platform for the most promising investment opportunities in emerging growth companies in healthcare and life sciences globally. Brett’s background as an entreprenuer includes founding the Minnesota Collaborative network that assists emerging companies. He also was founder and editor of Minnesota Ventures magazine and of Law & Politics magazine, now a Thomson Reuters publication called SuperLawyers. He founded an online network of 2,000 local drugstores throughout the U.S. Brett is now developing OneMedMarket, a secondary marketplace for trading shares of privately held healthcare and life science companies. He received his degree in economics from Harvard University.


Esther Dyson is Founder of HICCup and chairman of EDventure Holdings, Esther is an active angel investor, best-selling author, board member and advisor concentrating on emerging markets and technologies, new space and health. She sits on the boards of 23andMe and Voxiva (txt4baby), and is an investor in Crohnology, Eligible API, Keas, Omada Health, Sleepio, StartUp Health and Valkee, among others. From October 2008 to March of 2009, Esther lived in Star City outside Moscow, Russia, training as a backup cosmonaut.


Mony Weschler, Chief Applications Strategist and Architect, Applications Technology Services, Montefiore Medical Center, has more than 25 years of clinical IT informatics & management experience within leading academic healthcare systems. His work focuses on improving patient care with use of advanced clinical informatics specializing in medical imaging and innovation. He has held past positions as Technical Director Radiology Informatics at Mount Sinai Medical Center and was on the pioneering team that developed the first EHR at Columbia Presbyterian Medical Center.
As Director of Clinical Ancillary Systems for Emerging Health, Mony Weschler leads the strategic planning, development, and implementation of all clinical Ancillary Systems solutions and manages a team of 60 professionals for Montefiore Medical Center in Bronx and Westchester County, New York.
With over 22 years of clinical IT management experience, Mony leads the industry in implementing, integrating, and supporting clinical information systems and enhancing departmental workflow. With a specialty in Imaging Informatics, Mony’s subject matter expertise extends to Radiology, Cardiology, Pathology, Perioperative, Perinatal, Nuclear Medicine, Orthopedics and Pharmacy.


Sunny J. Barkats, Esq, is the founding Partner of new York based law firm of JSBarkats PLLC. He was recognized as a top corporate and securities attorney by his peers in the recent New York edition of Super Lawyers (a Thomson Reuters publication) which provides a peer rated list of the lawyers recommended by other lawyers.

His principal experience has been in private placements, mergers, acquisitions and dispositions, SEC compliance, public offerings, general 1933 and 1934 Act matters and strategic business relationships. He also represents issuers, underwriters, placement agents and others as well as lenders and financial participants, in mergers and acquisitions, IPOs, private equity, private placements and PIPE transactions.

Barkats is a national leader in Reg. A offerings having closed two Reg A financings during 2013 and 2014 more than any other law firm. He currently has two offerings in registration under the new Reg A+ which will become effective June 19th Barkats has also written extensively on the subject and currently collaborating with Growth Capital Report to create White Paper on Reg A+.


Tyler Gellasch is a Founder of Myrtle Makena, LLC, a New York-based financial services consulting firm. Amongst other clients, Gellasch advises W.R. Hambrecht + Co., LLC. Gellasch previously spent five years in the US Senate, first as Counsel for securities, banking, and tax matters for Senator Carl Levin (D-MI), and later as Senior Counsel to the Permanent Subcommittee on Investigations (PSI). While in the Senate, Gellasch played a key role in drafting portions of the Dodd-Frank Act, the JOBS Act, the STOCK Act, and assisted with several hearings and reports of the PSI. Gellasch also spent one year as Counsel to then-new SEC Commissioner Kara M. Stein. While there, he advised the Commissioner on equities and fixed income market reforms, Dodd-Frank Act and JOBS Act implementation, and other matters. Before working on Capitol Hill, Gellasch was an associate at the law firms of Mayer Brown LLP and Morgan Lewis & Bockius LLP. Gellasch received his B.A. from Case Western Reserve University, his M.A. (Economics) from Duke University Graduate School, and his J.D. from Duke University School of Law.


Artem Petakov, Co-Founder & Co-CEO,
Artem fell in love with programming at age nine, and has not stopped making software since. In his teens, he took key roles in several dot-coms, before going on to study at Princeton University. While earning his B.A. in Computer Science (Finance Minor), he interned at Microsoft’s SQL Server and Sun Solaris groups, learning life-long lessons in running software teams. He won the Robocup World Championship in 2005. From 2005-2008, he founded and then led the User-Created Map Content team at Google, a project described as a “pioneering” effort that will “transform” GIS. At Noom, Artem oversees all software engineering and product development efforts.


Sander Duncan is a founding member of North Shore Ventures (NSV), North Shore-LIJ’s corporate venture group. He manages NSV’s New Ventures team, focused on strategic investments and partnerships, developing business strategies for spin-off companies and identifying novel non-clinical revenue streams for the largest healthcare system in New York State. Sander also advises early- and growth-stage healthcare companies and is a Mentor at Blueprint Health, a New York-based healthcare IT accelerator and investment fund. He joined NSV from Cleveland Clinic Innovations (CCI), Cleveland Clinic’s corporate venture group, where he managed CCI’s strategic alliance with North Shore-LIJ and worked with CCI’s New Ventures team on early-stage investments across all healthcare sectors. Prior to joining CCI, Sander was an Associate at HealthpointCaptial, LLC, a healthcare growth equity firm focused on the middle market medical device sector. Previously, Sander was a researcher at Dartmouth Medical School studying genetic factors in rheumatoid arthritis. He holds a degree in Molecular Biology from Dartmouth College.


Anthony S. Manson is a digital healthcare leader having produced dozens of award winning programs engaging and educating patients & physicians over his 25-year career. He currently is Chief Organizer of Health 2.0 NYC, the largest of 90local chapters of Health 2.0 dedicated to accelerating health technology in their communities. Anthony is currently Chief Digital Officer at “/alert”, a division of Jobson Healthcare Information. He recently launched, a new “Performance Medicine” resource for physicians looking to improve patient outcomes in the new world of pay for performance medicine.

From 2010 to 2014 was VP Business Development at Everyday Health Inc. and was active in creating 360 degree Patient and Physician Solutions.

He also serves as a strategic advisor to Medstartr LLC the leading crowdfunding health solution in the U.S. as well as other start up digital health companies.